MASS TRANSPORTATION CAPITAL PROJECT AGREEMENTCapital Project Agreement • April 22nd, 2019 • New York
This agreement identifies the party responsible for administration, and establishes the method or provision for funding, of applicable phases of mass transportation capital project(s) to support public transportation systems, as more fully described by Schedule A annexed to this agreement, or one or more duly executed and approved Supplemental Schedules A to this agreement. The amount of NYSDOT’s grant pursuant to this agreement shall be limited to reimbursement of Project Eligible Costs actually incurred, in no event to exceed $1,239,303 (the “Grant”)
EX-10.17 4 d517182dex1017.htm EX-10.17 [***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so...Capital Project Agreement • May 5th, 2020 • Pennsylvania
This Agreement (the “Agreement”), is effective May 10, 2012 (the “Effective Date”) and is made by and between Iroko Pharmaceuticals, LLC, a Delaware limited liability company, whose principal place of business is at The Navy Yard Corporate Center, One Crescent Drive, Suite 400, Philadelphia, Pennsylvania 19112 (“Iroko”) and Catalent CTS, Inc., formerly known as Aptuit, Inc., a Delaware corporation, with offices located at 10245 Hickman Mills Drive, Kansas City, MO 64137 (“Catalent”).
NATURE IN THE CITY CAPITAL PROJECT AGREEMENTCapital Project Agreement • November 14th, 2019
THIS AGREEMENT is made and entered into this day of , 20 , by and between the CITY OF FORT COLLINS, COLORADO, a municipal corporation (the "City"), and (the "Grantee"), whose address is Fort Collins, Colorado.
